Natixis Advisors’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $784K | Buy |
69,535
+33,102
| +91% | +$373K | ﹤0.01% | 1370 |
|
|
2025
Q1 | $368K | Sell |
36,433
-15,187
| -29% | -$153K | ﹤0.01% | 1515 |
|
|
2024
Q4 | $611K | Sell |
51,620
-102,097
| -66% | -$1.21M | ﹤0.01% | 1426 |
|
|
2024
Q3 | $1.77M | Buy |
153,717
+11,726
| +8% | +$135K | ﹤0.01% | 1123 |
|
|
2024
Q2 | $1.5M | Buy |
141,991
+15,280
| +12% | +$161K | ﹤0.01% | 1138 |
|
|
2024
Q1 | $1.34M | Buy |
126,711
+64,352
| +103% | +$679K | ﹤0.01% | 1136 |
|
|
2023
Q4 | $699K | Buy |
+62,359
| New | +$699K | ﹤0.01% | 1318 |
|